BMY (bristol myers squibb) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BMY (bristol myers squibb)

BMY 45.62

-0.9%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Alys Hall who wrote (30)	5/3/1998 9:50:00 PM
From: Starlight	Read Replies (2) of 194

Tonight on the CBS network news, their lead story was about a new class of drugs that have a 98% cure rate of cancers in MICE. The drugs are angiostatin and endostatin. I was curious about who makes these drugs, so I used a Search Engine on ANGIOSTATIN. This is one of the sites I found: Angiostatin Licencing Bristol-Myers Squibb and EntreMed have announced an agreement whereby Bristol-Myers obtains exclusive worldwide licensing rights to EntreMed's developmental antiangiogenic products thalidomide, thalidomide analogs and Angiostatin. The first clinical trials on these compounds in the treatment of cancer are expected in 1996. CBS news reported that human trials on these new cancer drugs would probably begin before the end of this year. Does anyone else have any info on this?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next